Richard E. Byrd serves as the Executive Vice President and President of the Interventional Segment at Becton Dickinson (BD), a leading global medical technology company. In his current role, Byrd is responsible for overseeing the strategic direction and operational performance of BD's Interventional segment, which focuses on developing and delivering innovative medical devices and solutions for vascular, urology, and oncology applications. His leadership has been instrumental in driving growth and advancing BD's mission to improve patient outcomes and enhance the healthcare experience. Before joining BD, Byrd held several senior leadership positions in the healthcare and medical device industry. He has a proven track record of successfully leading business units, driving product innovation, and fostering a culture of continuous improvement. Byrd's extensive experience and deep understanding of the medical device market have enabled him to effectively navigate the complex challenges facing the industry, while capitalizing on opportunities to expand BD's portfolio and global reach. Under Byrd's leadership, BD's Interventional segment has achieved significant milestones, including the development and launch of groundbreaking products that have improved patient care and clinical outcomes. His strategic vision and commitment to excellence have positioned the segment for sustained growth and success. Byrd's collaborative approach and focus on empowering his team have fostered a dynamic and innovative work environment, further strengthening BD's position as a leader in the medical technology industry.